32 companies · NSE & BSE · Updated daily
The Indian healthcare services sector is demonstrating robust growth, driven by rising incomes, increased health awareness, and government initiatives. This segment, encompassing hospitals, diagnostic chains, and specialized clinics, is attracting significant investor interest on the back of strong fundamentals and a favourable demand outlook.
The sector's expansion is underpinned by a growing need for quality medical care, particularly in Tier 2 and Tier 3 cities. Key players are focusing on increasing bed capacities, adopting advanced medical technologies, and enhancing operational efficiencies. Metrics like Average Revenue Per Occupied Bed (ARPOB) and patient volume are showing upward trends, signaling strong business momentum. Furthermore, the increasing penetration of health insurance is a significant tailwind, boosting affordability and demand for services.
What to Watch
Investors should monitor regulatory changes by bodies like NHA, pricing pressures on certain procedures, and the pace of expansion into non-metro areas. Competitive intensity among hospital chains and the ability to maintain high occupancy rates and medical tourism inflows are critical factors to watch.
What are the key growth drivers for Indian healthcare services?
Key drivers include rising disposable incomes, a growing middle class, increased health consciousness, expansion of health insurance coverage, and government focus on healthcare infrastructure.
How is the sector performing in terms of profitability?
Profitability is generally strong, with leading players showing healthy Return on Equity (ROE) and improving operating margins, driven by economies of scale and operational efficiencies.
What are the main risks for healthcare service providers?
Risks include regulatory interventions on pricing, intense competition, dependence on skilled medical professionals, and potential challenges in scaling operations rapidly.
Are Indian healthcare stocks currently undervalued?
Valuations vary significantly. While some high-growth stocks trade at premium multiples, opportunities may exist in companies with strong balance sheets and consistent earnings growth that are yet to be fully recognized by the market.
| # | Company | Symbol | Price | Change | Market Cap |
|---|---|---|---|---|---|
| 1 | Dr Lal PathLabs Ltd | LALPATHLAB | ₹1577.30 | -1.87% | ₹25.6K Cr |
| 2 | Vijaya Diagnostic Centre Ltd | VIJAYA | ₹1240.90 | -5.17% | ₹10.3K Cr |
| 3 | Metropolis Healthcare Ltd | METROPOLIS | ₹540.85 | -2.61% | ₹10.1K Cr |
| 4 | Thyrocare Technologies Ltd | THYROCARE | ₹522.35 | +3.17% | ₹7.7K Cr |
| 5 | Krsnaa Diagnostics Ltd | KRSNAA | ₹541.60 | -1.43% | ₹2.6K Cr |
| 6 | Suraksha Diagnostic Ltd | SURAKSHA | ₹281.70 | -1.43% | ₹1.5K Cr |
| 7 | 3B Blackbio Diagnostics Ltd | 3BBLACKBIO | ₹1105.25 | -11.16% | ₹1.1K Cr |
| 8 | One Global Service Provider Inc | ONEGLOBAL | ₹467.55 | +5.00% | ₹1.1K Cr |
| 9 | Sastasundar Ventures Ltd | SASTASUNDR | ₹307.25 | -1.40% | ₹1.0K Cr |
| 10 | CHANDAN HEALTHCARE LTD | CHANDAN | ₹228.70 | -3.50% | ₹0.8K Cr |
| 11 | Star Imaging | 544482 | ₹133.00 | +0.00% | ₹0.2K Cr |
| 12 | Choksi Imaging Ltd | CHOKSI | ₹132.60 | +0.00% | ₹0.1K Cr |
| 13 | Aspira Pathlab & Diagnostics Limited | ASPIRA | ₹130.65 | -1.98% | ₹0.1K Cr |
| 14 | Bandaram Pharma Packtech Ltd | BANDARAM | ₹28.45 | +5.33% | ₹0.1K Cr |
| 15 | Samsrita Labs Ltd | SAMSRITA | ₹14.53 | -1.02% | ₹0.0K Cr |
| 16 | Medinova Diagnostic Services Inc | MEDINOV | ₹43.45 | +0.00% | ₹0.0K Cr |
| 17 | N G Industries | 530897 | ₹118.15 | -4.33% | ₹0.0K Cr |
| 18 | Sharma East India Hospitals & Medical Research Ltd | SHARMEH | ₹104.50 | -3.40% | ₹0.0K Cr |
| 19 | Deccan Healthcar | 542248 | ₹12.85 | +0.55% | ₹0.0K Cr |
| 20 | Chennai Meenakshi Multispeciality Hospital Ltd | CMMHOSP | ₹39.30 | +1.58% | ₹0.0K Cr |
| 21 | Tejnaksh Healthcare Ltd | TEJNAKSH | ₹15.24 | -0.65% | ₹0.0K Cr |
| 22 | Nidan Laboratories & Healthcare Limited | NIDAN | ₹14.00 | +0.00% | ₹0.0K Cr |
| 23 | Transgene Biotek Ltd | TRABI | ₹3.10 | -1.59% | ₹0.0K Cr |
| 24 | Family Care Hospitals Ltd | FAMILYCARE | ₹3.03 | -5.31% | ₹0.0K Cr |
| 25 | Gian Life Care Ltd | GIANLIFE | ₹6.00 | +4.53% | ₹0.0K Cr |
| 26 | Clinitech Laboratory Ltd | CTLLAB | ₹37.80 | -6.44% | ₹0.0K Cr |
| 27 | Dhanvantri Jeevan Rekha Ltd | ZDHJERK | ₹19.70 | +0.00% | ₹0.0K Cr |
| 28 | Dr Lalchandani Labs Ltd | DLCL | ₹9.97 | -0.20% | ₹0.0K Cr |
| 29 | Ashram Onlinecom Ltd | ASHRAM | ₹5.09 | -4.68% | ₹0.0K Cr |
| 30 | Boston Bio Systems Ltd | BOSTONBIO | ₹7.49 | +0.00% | ₹0.0K Cr |